Hep C in the News
A lot of progress has been made during the last 12 months in the fight against hepatitis C (HCV). We've seen new recommendations that all baby boomers get tested for HCV; and two new drugs to treat HCV were approved by the FDA, with more on the way.
All these developments have caught the attention of the national media. Click on the articles below to read some of the latest news.
Hepatitis C: New Drug Treatment "is a breakthrough," BBC, April 2014
"A new treatment for hepatitis C "cured" 90% of patients with the infection in 12 weeks, scientists said..."
Drugmaker Studies Find a Bargain in $84,000 Medicine, Bloomberg, April 2014
"While the $84,000 price of Gilead Sciences Inc.’s Sovaldi has riled lawmakers and public health advocates, doctors say this new generation of hepatitis C drugs may actually help cut costs..."
Lawmakers Attack Cost of New Hep C Drug, New York Times, March 2014
"A new drug to treat hepatitis C that costs $1,000 a pill has caused rising concern among insurers and state Medicaid programs..."
Gilead Offers Egypt New Hepatitis C Drug at 99% Discount, Reuters, March 2014
"(Reuters) - Gilead Sciences, facing mounting criticism over the high price of its new hepatitis C pill Sovaldi, has offered to supply the medicine to Egypt at a 99 percent discount to the U.S. price..."
How Much Should Hepatitis C Treatment Cost?, New York Times, March 2014
"A new pill to treat hepatitis C raises difficult questions about fair pricing, not only in the United States and other affluent nations but in developing countries around the world..."
One in 100 Americans has Chronic Hepatitis C Infection, Reuters, March 2014
"(Reuters Health) - At least one percent of Americans are chronically infected with the hepatitis C virus, which over time can severely damage the liver, according to a new study..."
Progress Against Hepatitis C, A Sneaky Virus, New York Times, February 2014
"Forty years ago, a beloved neighbor was bedridden for weeks at a time with a mysterious ailment. She knew only that it involved her liver and that she must never drink alcohol, which would make things worse..."
FDA Approves Pill to Treat Hepatitis C, New York Times, December 2013
"The Food and Drug Administration on Friday approved a pill that is expected to make the treatment of hepatitis C less onerous, shorter in duration and more effective..."
Hepatitis C, a Silent Killer, Meets its Match, New York Times, November 2013
'Determined to get rid of the hepatitis C infection that was slowly destroying his liver, Arthur Rubens tried one experimental treatment after another. None worked, and most brought side effects, like fever, insomnia, depression, anemia and a rash that “felt like your skin was on fire...”'